Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 32.53%
March 31, 2026 31.30%
December 31, 2025 31.25%
September 30, 2025 32.35%
June 30, 2025 32.78%
March 31, 2025 31.30%
December 31, 2024 31.71%
September 30, 2024 31.51%
June 30, 2024 32.37%
March 31, 2024 31.91%
December 31, 2023 31.16%
September 30, 2023 31.76%
June 30, 2023 32.68%
March 31, 2023 32.78%
December 31, 2022 31.63%
September 30, 2022 34.15%
June 30, 2022 33.55%
March 31, 2022 36.04%
December 31, 2021 36.59%
September 30, 2021 39.15%
June 30, 2021 38.12%
March 31, 2021 39.63%
December 31, 2020 42.24%
September 30, 2020 42.82%
June 30, 2020 33.83%
Date Value
March 31, 2020 29.31%
December 31, 2019 33.44%
September 30, 2019 34.56%
June 30, 2019 34.51%
March 31, 2019 33.53%
December 31, 2018 32.63%
September 30, 2018 34.73%
June 30, 2018 35.38%
March 31, 2018 34.39%
December 31, 2017 35.34%
September 30, 2017 35.88%
June 30, 2017 36.86%
March 31, 2017 35.61%
December 31, 2016 37.29%
September 30, 2016 38.14%
June 30, 2016 39.14%
March 31, 2016 38.00%
December 31, 2015 37.37%
September 30, 2015 38.19%
June 30, 2015 38.13%
March 31, 2015 36.70%
December 31, 2014 36.59%
September 30, 2014 37.60%
June 30, 2014 37.54%
March 31, 2014 36.37%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Labcorp Holdings, Inc. 27.71%
DaVita, Inc. 27.98%
OPKO Health, Inc. 37.32%
Psychemedics Corp. --
NeoGenomics, Inc. 44.06%

Gross Profit Margin (Quarterly) Related Metrics